Approval · Notice of Compliance 25936 · 2021
ABECMA: Notice of Compliance 25936
Issued May 26, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
Issued with conditions (NOC/c): the company must confirm the benefit in further studies.
- Notice number
- 25936
- Date
- May 26, 2021
- Company
- Celgene IncSaint-Laurent, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- With conditions
- Yes (NOC/c)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ABECMA | 02516233 | Cancelled Pre Market |
Medicinal ingredients
- IDECABTAGENE VICLEUCEL 520 CAR-TC per DOSE